Global Custom Market Research Reports Provider Company

phone

Chronic Pain Global Clinical Trials Review, H1, 2017

  • Published Date: 30 Jun 2017
  • Number of Pages: 489
  • Category: Healthcare and Medical
  • Country: Global
Chronic Pain Global Clinical Trials Review, H1, 2017

Summary

GlobalDatas clinical trial report, Chronic Pain Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Publisher Name : GlobalData
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Chronic Pain to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Chronic Pain to Central Nervous System Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Chronic Pain Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Chronic Pain 38
May 18, 2017: Egalet Announces Results of ARYMO ER Harm Reduction Modeling Analysis 38
May 17, 2017: Egalet Announces ARYMO ER Data Published in Journal of Opioid Management and American Journal of Drug and Alcohol Abuse 38
May 12, 2017: Antibe Therapeutics Engages Topstone Research and Appoints Dr. Francis Chan as Key Advisor for Phase 2 Clinical Trial of ATB-346 39
May 10, 2017: Centrexion Therapeutics to Present Data on CNTX-4975 for the Treatment of Chronic Pain Associated with Mortons Neuroma and Knee Osteoarthritis at American Pain Society 2017 Annual Scientific Meeting 39
Apr 25, 2017: Kineta to Present at Symposium on Next-Generation Therapeutics for the Treatment of Pain 39
Apr 18, 2017: Antibe Therapeutics Provides Update on Clinical Development Program for its Lead Drug, ATB-346 40
Apr 05, 2017: Kineta to Present at the 24th Annual Future Leaders in the Biotech Industry Conference 40
Clinical Trial Profile Snapshots 41
Appendix 487
Abbreviations 487
Definitions 487
Research Methodology 488
Secondary Research 488
About GlobalData 489
Contact Us 489
Source 489

List Of Tables


Chronic Pain Therapeutics, Global, Clinical Trials by Region, 2017* 7
Chronic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Chronic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Chronic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Chronic Pain Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Chronic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Chronic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Chronic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 17
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Chronic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 22
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Chronic Pain Therapeutics, Global, Clinical Trials by Phase, 2017* 26
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
Chronic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Chronic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Chronic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Chronic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
Chronic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Chronic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Chronic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List Of Figures


Chronic Pain Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Chronic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Chronic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Chronic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Chronic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Chronic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Chronic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Chronic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Chronic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Chronic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
Chronic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Chronic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Chronic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Chronic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
Chronic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Chronic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Chronic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
GlobalData Methodology 488

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2017 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline

View Report

Chronic Cough Global Clinical Trials Review, H2, 2017 GlobalDatas clinical trial report, Chronic Cough Global Clinical Trials Review, H2, 2017 provides an overview of Chronic Cough clinical trials scenario. This report

View Report

Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2017 GlobalDatas clinical trial report, Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2017 provides an overview of Hyperphosphatemia

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports